Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of medicinal chemistry Jg. 230; S. 114027 - 114037
Hauptverfasser:	Papanastasiou, Ioannis P., Georgiadis, Markos-Orestis, Iliopoulos-Tsoutsouvas, Christos, Paronis, Carol A., Brust, Christina A., Tran, Ngan K., Ji, Lipin, Ma, Xiaoyu, Wood, JodiAnne T., Zvonok, Nikolai, Tong, Fei, Bohn, Laura M., Nikas, Spyros P., Makriyannis, Alexandros
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	ISSY-LES-MOULINEAUX Elsevier Masson SAS 15.02.2022 Elsevier
Schlagworte:	Cannabinoids CB1 receptor Chemistry, Medicinal Dronabinol - analogs & derivatives Dronabinol - pharmacology Life Sciences & Biomedicine Nabilone analogs Pharmacology & Pharmacy Receptor, Cannabinoid, CB1 - agonists SAR studies Science & Technology Structure-Activity Relationship SAR studies Cannabinoids Nabilone analogs CB1 receptor AM2389 SIDE-CHAIN LIGAND
ISSN:	0223-5234, 1768-3254, 1768-3254
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side chain with varying chain lengths and terminal substitutions. Of the compounds described here, a nabilone analog, AM8936, with the C6′-cyano-substituted side chain, was identified as the most successful analog capable of serving as a potential candidate for further development and a valuable tool for further in vivo studies. AM8936 behaved as a balanced and potent CB1 agonist in functional assays and was a potent and efficacious CB1 agonist in vivo. Our SAR studies are highlighted with the docking of AM8936 on the crystal structure of the hCB1 receptor. [Display omitted] •We explored the C3 side-chain in the hexahydrocannabinol template in terms of chain length and terminal substitution.•The cyclobutyl nabilone analog AM8936 with C6′ cyano-substitution was the most successful.•AM8936 behaved as a balanced and potent CB1 agonist in functional assays.•AM8936 behaved as a potent CB1 agonist in vivo.•Our structure activity relationships are highlighted via docking on the hCB1 crystal structure.
AbstractList	In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side chain with varying chain lengths and terminal substitutions. Of the compounds described here, a nabilone analog, AM8936, with the C6'-cyano-substituted side chain, was identified as the most successful analog capable of serving as a potential candidate for further development and a valuable tool for further in vivo studies. AM8936 behaved as a balanced and potent CB1 agonist in functional assays and was a potent and efficacious CB1 agonist in vivo. Our SAR studies are highlighted with the docking of AM8936 on the crystal structure of the hCB1 receptor.In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side chain with varying chain lengths and terminal substitutions. Of the compounds described here, a nabilone analog, AM8936, with the C6'-cyano-substituted side chain, was identified as the most successful analog capable of serving as a potential candidate for further development and a valuable tool for further in vivo studies. AM8936 behaved as a balanced and potent CB1 agonist in functional assays and was a potent and efficacious CB1 agonist in vivo. Our SAR studies are highlighted with the docking of AM8936 on the crystal structure of the hCB1 receptor. In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side chain with varying chain lengths and terminal substitutions. Of the compounds described here, a nabilone analog, AM8936, with the C6'-cyano-substituted side chain, was identified as the most successful analog capable of serving as a potential candidate for further development and a valuable tool for further in vivo studies. AM8936 behaved as a balanced and potent CB1 agonist in functional assays and was a potent and efficacious CB1 agonist in vivo. Our SAR studies are highlighted with the docking of AM8936 on the crystal structure of the hCB1 receptor. In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side chain with varying chain lengths and terminal substitutions. Of the compounds described here, a nabilone analog, AM8936, with the C6′-cyano-substituted side chain, was identified as the most successful analog capable of serving as a potential candidate for further development and a valuable tool for further in vivo studies. AM8936 behaved as a balanced and potent CB1 agonist in functional assays and was a potent and efficacious CB1 agonist in vivo. Our SAR studies are highlighted with the docking of AM8936 on the crystal structure of the hCB1 receptor. [Display omitted] •We explored the C3 side-chain in the hexahydrocannabinol template in terms of chain length and terminal substitution.•The cyclobutyl nabilone analog AM8936 with C6′ cyano-substitution was the most successful.•AM8936 behaved as a balanced and potent CB1 agonist in functional assays.•AM8936 behaved as a potent CB1 agonist in vivo.•Our structure activity relationships are highlighted via docking on the hCB1 crystal structure. In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted in the development of AM2389. In an effort for further optimization, we have merged features of nabilone and AM2389 and explored the C3 side chain with varying chain lengths and terminal substitutions. Of the compounds described here, a nabilone analog, AM8936, with the C6'-cyano-substituted side chain, was identified as the most successful analog capable of serving as a potential candidate for further development and a valuable tool for further in vivo studies. AM8936 behaved as a balanced and potent CB1 agonist in functional assays and was a potent and efficacious CB1 agonist in vivo. Our SAR studies are highlighted with the docking of AM8936 on the crystal structure of the hCB1 receptor. (C) 2021 Published by Elsevier Masson SAS.
ArticleNumber	114027
Author	Wood, JodiAnne T. Tong, Fei Ma, Xiaoyu Makriyannis, Alexandros Georgiadis, Markos-Orestis Papanastasiou, Ioannis P. Brust, Christina A. Bohn, Laura M. Paronis, Carol A. Ji, Lipin Iliopoulos-Tsoutsouvas, Christos Tran, Ngan K. Zvonok, Nikolai Nikas, Spyros P.
Author_xml	– sequence: 1 givenname: Ioannis P. orcidid: 0000-0001-6974-2561 surname: Papanastasiou fullname: Papanastasiou, Ioannis P. organization: Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157-84, Athens, Greece – sequence: 2 givenname: Markos-Orestis surname: Georgiadis fullname: Georgiadis, Markos-Orestis organization: Division of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 157-84, Athens, Greece – sequence: 3 givenname: Christos orcidid: 0000-0003-3750-431X surname: Iliopoulos-Tsoutsouvas fullname: Iliopoulos-Tsoutsouvas, Christos organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 4 givenname: Carol A. orcidid: 0000-0002-3203-1966 surname: Paronis fullname: Paronis, Carol A. organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 5 givenname: Christina A. orcidid: 0000-0003-2849-0040 surname: Brust fullname: Brust, Christina A. organization: Skaggs Graduate School of Chemical and Biological Science and Department of Molecular Medicine, Scripps Florida, Jupiter, FL, 33458, USA – sequence: 6 givenname: Ngan K. surname: Tran fullname: Tran, Ngan K. organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 7 givenname: Lipin orcidid: 0000-0001-9956-3855 surname: Ji fullname: Ji, Lipin organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 8 givenname: Xiaoyu orcidid: 0000-0002-9612-4774 surname: Ma fullname: Ma, Xiaoyu organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 9 givenname: JodiAnne T. surname: Wood fullname: Wood, JodiAnne T. organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 10 givenname: Nikolai orcidid: 0000-0002-1749-7688 surname: Zvonok fullname: Zvonok, Nikolai organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 11 givenname: Fei surname: Tong fullname: Tong, Fei organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 12 givenname: Laura M. orcidid: 0000-0002-6474-8179 surname: Bohn fullname: Bohn, Laura M. organization: Department of Molecular Medicine, Scripps Florida, Jupiter, FL, USA – sequence: 13 givenname: Spyros P. surname: Nikas fullname: Nikas, Spyros P. organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA – sequence: 14 givenname: Alexandros orcidid: 0000-0003-3272-3687 surname: Makriyannis fullname: Makriyannis, Alexandros email: a.makriyannis@northeastern.edu organization: Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/35051750$$D View this record in MEDLINE/PubMed
BookMark	eNqNkcFu1DAQhi1URLcLb4BQjkgoy9iJE4cDUkkLVKrEBc6WY4-LV4m9xE7Rvj2usvTAATjZsr5vPDP_BTnzwSMhLynsKNDm7X6H-wn19x0DRneU1sDaJ2RD20aUFeP1GdkAY1XJWVWfk4sY9wDAG4Bn5LziwGnLYUOubqbDHO7RFPqoxzAs6TgWXg1uzL8Vyqsx3MVCxeIQEvpU9B9oMaPGQwpzoe6CdzHF5-SpVWPEF6dzS759vP7afy5vv3y66S9vS12DSCWKoVZa15ZXLTdda4VmFqhAYageBLOobFNRQxuO2mjs8utQ0Q4bNlgQptqS12vd3PKPBWOSk4sax1F5DEuUrGGMiYbnkbfk1QldhgmNPMxuUvNR_p48A29W4CcOwUbt0Gt8xPKqBO1a6ES-Ac20-H-6d0klF3wfFp-yWq-qnkOMM9pHjYJ8SFLu5ZqkfEhSrklm7d0fmj6VTbNy47_k96uMOY17h7M8tWxcDi9JE9zfC_wC8Dq5Ww
CitedBy_id	crossref_primary_10_1093_jat_bkae094 crossref_primary_10_1021_acs_jmedchem_5c00047 crossref_primary_10_1021_acs_jmedchem_5c02030 crossref_primary_10_3389_fpsyt_2024_1322434 crossref_primary_10_1016_j_ejphar_2023_176168
Cites_doi	10.1038/nrd.2018.115 10.1016/j.tet.2007.06.006 10.1021/jm501165d 10.1016/j.jagp.2019.05.002 10.1038/nature23272 10.1002/ana.25864 10.1007/s00213-015-3907-0 10.1021/jm050540c 10.1124/jpet.106.104109 10.1021/acs.jctc.5b00864 10.1111/ajad.12622 10.1021/acs.jmedchem.8b00611 10.1124/jpet.119.261818 10.1517/17460441.2012.714363 10.1002/med.21634 10.1021/acs.jmedchem.0c02053 10.1016/j.cell.2020.01.008 10.1021/jm070121a 10.1016/j.bmc.2018.08.003 10.1007/s10822-013-9644-8 10.1016/S0026-895X(25)10492-6 10.1021/jm301205j 10.1016/j.cell.2018.11.040 10.1021/jm100641g 10.1021/acs.jmedchem.6b00717 10.1016/j.cell.2016.10.004 10.1097/FBP.0b013e32835a7c4d 10.1038/s41582-019-0284-z 10.1016/j.jns.2020.116717 10.1016/j.pharmthera.2020.107477 10.1007/s00213-011-2491-1 10.4137/PMC.S32171
ContentType	Journal Article
Copyright	2021 Copyright © 2021. Published by Elsevier Masson SAS.
Copyright_xml	– notice: 2021 – notice: Copyright © 2021. Published by Elsevier Masson SAS.
DBID	AAYXX CITATION 17B 1KM AHQBO BLEPL DTL EGQ CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.ejmech.2021.114027
DatabaseName	CrossRef Web of Knowledge Index Chemicus Web of Science - Science Citation Index Expanded - 2022 Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE Web of Science
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Chemistry Pharmacy, Therapeutics, & Pharmacology
EISSN	1768-3254
ExternalDocumentID	35051750 000819709800001 10_1016_j_ejmech_2021_114027 S022352342100876X
Genre	Journal Article
GrantInformation_xml	– fundername: National Institute on Drug Abuse; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA) grantid: DA009158; DA041435
GroupedDBID	--- --K --M .~1 0R~ 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABFRF ABGSF ABJNI ABMAC ABOCM ABUDA ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA J1W KOM M2Y M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SES SPC SPCBC SSK SSP SSU SSZ T5K ~G- 1B1 29G 53G 9DU AAQXK AATTM AAXKI AAYWO AAYXX ABFNM ABWVN ABXDB ACLOT ACNNM ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AGRDE AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION EFKBS EJD FEDTE FGOYB G-2 HMS HMT HVGLF HZ~ IHE R2- SCB SEW SOC SPT WUQ ~HD 17B 1KM BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE BNPGV CGR CUY CVF ECM EIF NPM SSH 7X8
ID	FETCH-LOGICAL-c408t-e8b4acc4f5375d97f8c2f018e8d1cb82feaf631d165ecdce91cbb319e62bf08d3
ISICitedReferencesCount	6
ISICitedReferencesURI	https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000819709800001
ISSN	0223-5234 1768-3254
IngestDate	Sun Sep 28 11:56:27 EDT 2025 Thu Apr 03 07:08:13 EDT 2025 Mon Oct 27 23:26:35 EDT 2025 Fri Dec 05 22:59:20 EST 2025 Sat Nov 29 07:19:43 EST 2025 Tue Nov 18 22:29:23 EST 2025 Fri Feb 23 02:41:03 EST 2024
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	SAR studies Cannabinoids Nabilone analogs CB1 receptor AM2389 SIDE-CHAIN LIGAND
Language	English
License	Copyright © 2021. Published by Elsevier Masson SAS.
LinkModel	OpenURL
LogoURL	https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId	FETCHMERGED-LOGICAL-c408t-e8b4acc4f5375d97f8c2f018e8d1cb82feaf631d165ecdce91cbb319e62bf08d3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ORCID	0000-0001-9956-3855 0000-0003-2849-0040 0000-0002-9612-4774 0000-0003-3750-431X 0000-0002-3203-1966 0000-0002-6474-8179 0000-0001-6974-2561 0000-0003-3272-3687 0000-0002-1749-7688 0000-0003-2880-8135 0000-0002-9804-9675
OpenAccessLink	https://doi.org/10.7270/q2j96bfx
PMID	35051750
PQID	2622286552
PQPubID	23479
PageCount	11
ParticipantIDs	proquest_miscellaneous_2622286552 crossref_primary_10_1016_j_ejmech_2021_114027 pubmed_primary_35051750 webofscience_primary_000819709800001 webofscience_primary_000819709800001CitationCount crossref_citationtrail_10_1016_j_ejmech_2021_114027 elsevier_sciencedirect_doi_10_1016_j_ejmech_2021_114027
PublicationCentury	2000
PublicationDate	2022-02-15
PublicationDateYYYYMMDD	2022-02-15
PublicationDate_xml	– month: 02 year: 2022 text: 2022-02-15 day: 15
PublicationDecade	2020
PublicationPlace	ISSY-LES-MOULINEAUX
PublicationPlace_xml	– name: ISSY-LES-MOULINEAUX – name: France
PublicationTitle	European journal of medicinal chemistry
PublicationTitleAbbrev	EUR J MED CHEM
PublicationTitleAlternate	Eur J Med Chem
PublicationYear	2022
Publisher	Elsevier Masson SAS Elsevier
Publisher_xml	– name: Elsevier Masson SAS – name: Elsevier
References	Nikas, Sharma, Paronis, Kulkarni, Thakur, Hurst, Wood, Gifford, Rajarshi, Liu, Raghav, Guo, Jarbe, Reggio, Bergman, Makriyannis (bib29) 2015; 58 Martin, Wiley, Beletskaya, Sim-Selley, Smith, Dewey, Cottney, Adams, Baker, Hill, Saha, Zerkowski, Mahadevan, Razdan (bib24) 2006; 318 Kourounakis, Xanthopoulos, Tzara (bib20) 2020; 40 Peball, Krismer, Knaus, Djamshidian, Werkmann, Carbone, Ellmerer, Heim, Marini, Valent, Goebel, Ulmer, Stockner, Wenning, Stolz, Krejcy, Poewe, Seppi (bib7) 2020; 88 Krishna Kumar, Shalev-Benami, Robertson, Hu, Banister, Hollingsworth, Latorraca, Kato, Hilger, Maeda, Weis, Farrens, Dror, Malhotra, Kobilka, Skiniotis (bib11) 2019; 176 Hill, Palastro, Gruber, Fitzmaurice, Greenfield, Lukas, Weiss (bib8) 2017; 26 Hua, Li, Wu, Iliopoulos-Tsoutsouvas, Wang, Wu, Shen, Johnston, Nikas, Song, Song, Yuan, Sun, Wu, Jiang, Grim, Benchama, Stahl, Zvonok, Zhao, Bohn, Makriyannis, Liu (bib12) 2020; 180 Paronis, Nikas, Shukla, Makriyannis (bib17) 2012; 23 Jiang, Iliopoulos-Tsoutsouvas, Tong, Brust, Keenan, Raghav, Hua, Wu, Ho, Wu, Grim, Zvonok, Thakur, Liu, Sharkey, Bohn, Nikas, Makriyannis (bib19) 2021; 64 Arnott, Planey (bib25) 2012; 7 Cristino, Bisogno, Di Marzo (bib3) 2020; 16 Kangas, Zakarian, Vemuri, Alapafuja, Jiang, Nikas, Makriyannis, Bergman (bib15) 2020; 372 Malamas, Raghav, Ma, Honrao, Wood, Benchama, Zhou, Mallipeddi, Makriyannis (bib28) 2018; 26 Felder, Joyce, Briley, Mansouri, Mackie, Blond, Lai, Ma, Mitchell (bib26) 1995; 48 Harder, Damm, Maple, Wu, Reboul, Xiang, Wang, Lupyan, Dahlgren, Knight, Kaus, Cerutti, Krilov, Jorgensen, Abel, Friesner (bib34) 2016; 12 Cinar, Iyer, Kunos (bib2) 2020 Sherman, Day, Jacobson, Friesner, Farid (bib33) 2006; 49 Hua, Vemuri, Nikas, Laprairie, Wu, Qu, Pu, Korde, Jiang, Ho, Han, Ding, Li, Liu, Hanson, Zhao, Bohn, Makriyannis, Stevens, Liu (bib10) 2017; 547 Alapafuja, Nikas, Bharathan, Shukla, Nasr, Bowman, Zvonok, Li, Shi, Engen, Makriyannis (bib21) 2012; 55 Tai, Nikas, Shukla, Vemuri, Makriyannis, Jarbe (bib16) 2015; 232 Nikas, Thakur, Parrish, Alapafuja, Huestis, Makriyannis (bib22) 2007; 63 Di Marzo (bib5) 2018; 17 Levinsohn, Hill (bib4) 2020; 411 Sastry, Adzhigirey, Day, Annabhimoju, Sherman (bib32) 2013; 27 Iliopoulos-Tsoutsouvas, Georgiadis, Ji, Nikas, Makriyannis (bib1) 2020 Järbe, Tai, LeMay, Nikas, Shukla, Zvonok, Makriyannis (bib18) 2012; 220 Liu, Ji, Eno, Kudalkar, Li, Schimpgen, Benchama, Morales, Xu, Hurst, Wu, Mohammad, Wood, Zvonok, Papahatjis, Zhou, Honrao, Mackie, Reggio, Hohmann, Marnett, Makriyannis, Nikas (bib31) 2018; 61 Herrmann, Ruthirakuhan, Gallagher, Verhoeff, Kiss, Black, Lanctot (bib6) 2019; 27 Kulkarni, Nikas, Sharma, Jiang, Paronis, Leonard, Zhang, Honrao, Mallipeddi, Raghav, Benchama, Jarbe, Bergman, Makriyannis (bib30) 2016; 59 Nikas, Alapafuja, Papanastasiou, Paronis, Shukla, Papahatjis, Bowman, Halikhedkar, Han, Makriyannis (bib13) 2010; 53 Ballesteros, Weinstein (bib27) 1995; vol. 25 Papahatjis, Nahmias, Nikas, Andreou, Alapafuja, Tsotinis, Guo, Fan, Makriyannis (bib14) 2007; 50 Hua, Vemuri, Pu, Qu, Han, Wu, Zhao, Shui, Li, Korde, Laprairie, Stahl, Ho, Zvonok, Zhou, Kufareva, Wu, Zhao, Hanson, Bohn, Makriyannis, Stevens, Liu (bib9) 2016; 167 Bow, Rimoldi (bib23) 2016; 8 Nikas (10.1016/j.ejmech.2021.114027_bib22) 2007; 63 Arnott (10.1016/j.ejmech.2021.114027_bib25) 2012; 7 Felder (10.1016/j.ejmech.2021.114027_bib26) 1995; 48 Alapafuja (10.1016/j.ejmech.2021.114027_bib21) 2012; 55 Cristino (10.1016/j.ejmech.2021.114027_bib3) 2020; 16 Sastry (10.1016/j.ejmech.2021.114027_bib32) 2013; 27 Kangas (10.1016/j.ejmech.2021.114027_bib15) 2020; 372 Hua (10.1016/j.ejmech.2021.114027_bib9) 2016; 167 Harder (10.1016/j.ejmech.2021.114027_bib34) 2016; 12 Järbe (10.1016/j.ejmech.2021.114027_bib18) 2012; 220 Martin (10.1016/j.ejmech.2021.114027_bib24) 2006; 318 Paronis (10.1016/j.ejmech.2021.114027_bib17) 2012; 23 Jiang (10.1016/j.ejmech.2021.114027_bib19) 2021; 64 Iliopoulos-Tsoutsouvas (10.1016/j.ejmech.2021.114027_bib1) 2020 Tai (10.1016/j.ejmech.2021.114027_bib16) 2015; 232 Hua (10.1016/j.ejmech.2021.114027_bib10) 2017; 547 Ballesteros (10.1016/j.ejmech.2021.114027_bib27) 1995; vol. 25 Malamas (10.1016/j.ejmech.2021.114027_bib28) 2018; 26 Krishna Kumar (10.1016/j.ejmech.2021.114027_bib11) 2019; 176 Liu (10.1016/j.ejmech.2021.114027_bib31) 2018; 61 Di Marzo (10.1016/j.ejmech.2021.114027_bib5) 2018; 17 Nikas (10.1016/j.ejmech.2021.114027_bib13) 2010; 53 Peball (10.1016/j.ejmech.2021.114027_bib7) 2020; 88 Kulkarni (10.1016/j.ejmech.2021.114027_bib30) 2016; 59 Hua (10.1016/j.ejmech.2021.114027_bib12) 2020; 180 Kourounakis (10.1016/j.ejmech.2021.114027_bib20) 2020; 40 Hill (10.1016/j.ejmech.2021.114027_bib8) 2017; 26 Bow (10.1016/j.ejmech.2021.114027_bib23) 2016; 8 Cinar (10.1016/j.ejmech.2021.114027_bib2) 2020 Nikas (10.1016/j.ejmech.2021.114027_bib29) 2015; 58 Levinsohn (10.1016/j.ejmech.2021.114027_bib4) 2020; 411 Herrmann (10.1016/j.ejmech.2021.114027_bib6) 2019; 27 Sherman (10.1016/j.ejmech.2021.114027_bib33) 2006; 49 Papahatjis (10.1016/j.ejmech.2021.114027_bib14) 2007; 50 Nikas, SP (WOS:000252083800007) 2007; 63 Bow, EW (WOS:000383809500001) 2016; 8 Ballesteros, J.A. (000819709800001.27) 1995; 25 Kulkarni, S (WOS:000380730600022) 2016; 59 Jiang, S (WOS:000639043300020) 2021; 64 Hua, T (WOS:000386344100021) 2016; 167 Sastry, GM (WOS:000318411400002) 2013; 27 Cinar, R (WOS:000522634400012) 2020; 208 Alapafuja, SO (WOS:000311461500055) 2012; 55 Hua, T (WOS:000406358300039) 2017; 547 Arnott, JA (WOS:000309460800001) 2012; 7 Kourounakis, AP (WOS:000485789400001) 2020; 40 Kangas, BD (WOS:000507945200012) 2020; 372 Malamas, MS (WOS:000446669400001) 2018; 26 Nikas, SP (WOS:000348492100012) 2015; 58 Cristino, L (WOS:000505736100007) 2020; 16 Nikas, SP (WOS:000282544800017) 2010; 53 Tai, S (WOS:000358059700010) 2015; 232 Herrmann, N (WOS:000488523100001) 2019; 27 Martin, BR (WOS:000239878900035) 2006; 318 Iliopoulos-Tsoutsouvas, C. (000819709800001.1) 2020 Peball, M (WOS:000564540900001) 2020; 88 Sherman, W (WOS:000234836200015) 2006; 49 Kumar, KK (WOS:000456526100007) 2019; 176 Paronis, CA (WOS:000310921700009) 2012; 23 Järbe, TUC (WOS:000300781200016) 2012; 220 Hill, KP (WOS:000416114000005) 2017; 26 FELDER, CC (WOS:A1995RX63500009) 1995; 48 Levinsohn, EA (WOS:000525420400030) 2020; 411 Harder, E (WOS:000368322500026) 2016; 12 Di Marzo, V (WOS:000443169700010) 2018; 17 Papahatjis, DP (WOS:000248758600010) 2007; 50 Liu, YP (WOS:000447470700009) 2018; 61 Hua, T (WOS:000514846600005) 2020; 180
References_xml	– volume: 55 start-page: 10074 year: 2012 end-page: 10089 ident: bib21 article-title: Sulfonyl fluoride inhibitors of fatty acid amide hydrolase publication-title: J. Med. Chem. – volume: 16 start-page: 9 year: 2020 end-page: 29 ident: bib3 article-title: Cannabinoids and the expanded endocannabinoid system in neurological disorders publication-title: Nat. Rev. Neurol. – start-page: 48 year: 2020 end-page: 88 ident: bib1 article-title: Natural compounds and synthetic drugs to target type-1 cannabinoid (CB1) receptor publication-title: New Tools to Interrogate Endocannabinoid Signalling – volume: 23 start-page: 802 year: 2012 end-page: 805 ident: bib17 article-title: Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice publication-title: Behav. Pharmacol. – volume: 220 start-page: 417 year: 2012 end-page: 426 ident: bib18 article-title: AM2389, a high-affinity, in vivo potent CB 1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice publication-title: Psychopharmacology – volume: 61 start-page: 8639 year: 2018 end-page: 8657 ident: bib31 article-title: (R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): a novel chiral potent endocannabinoid ligand with stability to metabolizing enzymes publication-title: J. Med. Chem. – start-page: 107477 year: 2020 ident: bib2 article-title: The therapeutic potential of second and third generation CB1R antagonists publication-title: Pharmacol. Ther. – volume: 53 start-page: 6996 year: 2010 end-page: 7010 ident: bib13 article-title: Novel 1',1'-chain substituted hexahydrocannabinols: 9beta-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist publication-title: J. Med. Chem. – volume: 58 start-page: 665 year: 2015 end-page: 681 ident: bib29 article-title: Probing the carboxyester side chain in controlled deactivation (-)-delta(8)-tetrahydrocannabinols publication-title: J. Med. Chem. – volume: 27 start-page: 1161 year: 2019 end-page: 1173 ident: bib6 article-title: Randomized placebo-controlled trial of nabilone for agitation in Alzheimer's disease publication-title: Am. J. Geriatr. Psychiatr. – volume: 63 start-page: 8112 year: 2007 end-page: 8123 ident: bib22 article-title: A concise methodology for the synthesis of (−)-Δ9-tetrahydrocannabinol and (−)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs publication-title: Tetrahedron – volume: 547 start-page: 468 year: 2017 end-page: 471 ident: bib10 article-title: Crystal structures of agonist-bound human cannabinoid receptor CB1 publication-title: Nature – volume: 176 start-page: 448 year: 2019 end-page: 458 ident: bib11 article-title: Structure of a signaling cannabinoid receptor 1-G protein complex publication-title: Cell – volume: 8 start-page: 17 year: 2016 end-page: 39 ident: bib23 article-title: The structure–function relationships of classical cannabinoids: CB1/CB2 modulation publication-title: Perspect. Med. Chem. – volume: 59 start-page: 6903 year: 2016 end-page: 6919 ident: bib30 article-title: Novel C-Ring-hydroxy-substituted controlled deactivation cannabinergic analogues publication-title: J. Med. Chem. – volume: 180 start-page: 655 year: 2020 end-page: 665 ident: bib12 article-title: Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures publication-title: Cell – volume: 64 start-page: 3870 year: 2021 end-page: 3884 ident: bib19 article-title: Novel functionalized cannabinoid receptor probes: development of exceptionally potent agonists publication-title: J. Med. Chem. – volume: vol. 25 start-page: 366 year: 1995 end-page: 428 ident: bib27 article-title: Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors publication-title: Methods Neurosci – volume: 17 start-page: 623 year: 2018 end-page: 639 ident: bib5 article-title: New approaches and challenges to targeting the endocannabinoid system publication-title: Nat. Rev. Drug Discov. – volume: 50 start-page: 4048 year: 2007 end-page: 4060 ident: bib14 article-title: C1 ‘-cycloalkyl side chain pharmacophore in tetrahydrocannabinols publication-title: J. Med. Chem. – volume: 372 start-page: 119 year: 2020 end-page: 127 ident: bib15 article-title: Cannabinoid antagonist drug discrimination in nonhuman primates publication-title: J. Pharmacol. Exp. Therapeut. – volume: 318 start-page: 1230 year: 2006 end-page: 1239 ident: bib24 article-title: Pharmacological characterization of novel water-soluble cannabinoids publication-title: J. Pharmacol. Exp. Therapeut. – volume: 411 start-page: 116717 year: 2020 ident: bib4 article-title: Clinical uses of cannabis and cannabinoids in the United States publication-title: J. Neurol. Sci. – volume: 232 start-page: 2751 year: 2015 end-page: 2761 ident: bib16 article-title: Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist publication-title: Psychopharmacology (Berl) – volume: 49 start-page: 534 year: 2006 end-page: 553 ident: bib33 article-title: Novel procedure for modeling ligand/receptor induced fit effects publication-title: J. Med. Chem. – volume: 27 start-page: 221 year: 2013 end-page: 234 ident: bib32 article-title: Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments publication-title: J. Comput. Aided Mol. Des. – volume: 167 start-page: 750 year: 2016 end-page: 762 ident: bib9 article-title: Crystal structure of the human cannabinoid receptor CB1 publication-title: Cell – volume: 7 start-page: 863 year: 2012 end-page: 875 ident: bib25 article-title: The influence of lipophilicity in drug discovery and design publication-title: Expet Opin. Drug Discov. – volume: 48 start-page: 443 year: 1995 end-page: 450 ident: bib26 article-title: Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors publication-title: Mol. Pharmacol. – volume: 12 start-page: 281 year: 2016 end-page: 296 ident: bib34 article-title: OPLS3: a force field providing broad coverage of drug-like small molecules and proteins publication-title: J. Chem. Theor. Comput. – volume: 26 start-page: 795 year: 2017 end-page: 801 ident: bib8 article-title: Nabilone pharmacotherapy for cannabis dependence: a randomized, controlled pilot study publication-title: Am. J. Addict. – volume: 88 start-page: 712 year: 2020 end-page: 722 ident: bib7 article-title: Collaborators of the Parkinson's Disease Working Group, I., Non-motor symptoms in Parkinson's disease are reduced by nabilone publication-title: Ann. Neurol. – volume: 40 start-page: 709 year: 2020 end-page: 752 ident: bib20 article-title: Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules publication-title: Med. Res. Rev. – volume: 26 start-page: 4963 year: 2018 end-page: 4970 ident: bib28 article-title: Oximes short-acting CB1 receptor agonists publication-title: Bioorg. Med. Chem. – volume: 17 start-page: 623 issue: 9 year: 2018 ident: 10.1016/j.ejmech.2021.114027_bib5 article-title: New approaches and challenges to targeting the endocannabinoid system publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd.2018.115 – volume: 63 start-page: 8112 issue: 34 year: 2007 ident: 10.1016/j.ejmech.2021.114027_bib22 article-title: A concise methodology for the synthesis of (−)-Δ9-tetrahydrocannabinol and (−)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs publication-title: Tetrahedron doi: 10.1016/j.tet.2007.06.006 – volume: 58 start-page: 665 issue: 2 year: 2015 ident: 10.1016/j.ejmech.2021.114027_bib29 article-title: Probing the carboxyester side chain in controlled deactivation (-)-delta(8)-tetrahydrocannabinols publication-title: J. Med. Chem. doi: 10.1021/jm501165d – volume: 27 start-page: 1161 issue: 11 year: 2019 ident: 10.1016/j.ejmech.2021.114027_bib6 article-title: Randomized placebo-controlled trial of nabilone for agitation in Alzheimer's disease publication-title: Am. J. Geriatr. Psychiatr. doi: 10.1016/j.jagp.2019.05.002 – volume: 547 start-page: 468 issue: 7664 year: 2017 ident: 10.1016/j.ejmech.2021.114027_bib10 article-title: Crystal structures of agonist-bound human cannabinoid receptor CB1 publication-title: Nature doi: 10.1038/nature23272 – volume: 88 start-page: 712 issue: 4 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib7 article-title: Collaborators of the Parkinson's Disease Working Group, I., Non-motor symptoms in Parkinson's disease are reduced by nabilone publication-title: Ann. Neurol. doi: 10.1002/ana.25864 – volume: 232 start-page: 2751 issue: 15 year: 2015 ident: 10.1016/j.ejmech.2021.114027_bib16 article-title: Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-015-3907-0 – volume: 49 start-page: 534 issue: 2 year: 2006 ident: 10.1016/j.ejmech.2021.114027_bib33 article-title: Novel procedure for modeling ligand/receptor induced fit effects publication-title: J. Med. Chem. doi: 10.1021/jm050540c – volume: 318 start-page: 1230 issue: 3 year: 2006 ident: 10.1016/j.ejmech.2021.114027_bib24 article-title: Pharmacological characterization of novel water-soluble cannabinoids publication-title: J. Pharmacol. Exp. Therapeut. doi: 10.1124/jpet.106.104109 – volume: 12 start-page: 281 issue: 1 year: 2016 ident: 10.1016/j.ejmech.2021.114027_bib34 article-title: OPLS3: a force field providing broad coverage of drug-like small molecules and proteins publication-title: J. Chem. Theor. Comput. doi: 10.1021/acs.jctc.5b00864 – volume: 26 start-page: 795 issue: 8 year: 2017 ident: 10.1016/j.ejmech.2021.114027_bib8 article-title: Nabilone pharmacotherapy for cannabis dependence: a randomized, controlled pilot study publication-title: Am. J. Addict. doi: 10.1111/ajad.12622 – volume: 61 start-page: 8639 issue: 19 year: 2018 ident: 10.1016/j.ejmech.2021.114027_bib31 article-title: (R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): a novel chiral potent endocannabinoid ligand with stability to metabolizing enzymes publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.8b00611 – start-page: 48 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib1 article-title: Natural compounds and synthetic drugs to target type-1 cannabinoid (CB1) receptor – volume: 372 start-page: 119 issue: 1 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib15 article-title: Cannabinoid antagonist drug discrimination in nonhuman primates publication-title: J. Pharmacol. Exp. Therapeut. doi: 10.1124/jpet.119.261818 – volume: 7 start-page: 863 issue: 10 year: 2012 ident: 10.1016/j.ejmech.2021.114027_bib25 article-title: The influence of lipophilicity in drug discovery and design publication-title: Expet Opin. Drug Discov. doi: 10.1517/17460441.2012.714363 – volume: 40 start-page: 709 issue: 2 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib20 article-title: Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules publication-title: Med. Res. Rev. doi: 10.1002/med.21634 – volume: 64 start-page: 3870 issue: 7 year: 2021 ident: 10.1016/j.ejmech.2021.114027_bib19 article-title: Novel functionalized cannabinoid receptor probes: development of exceptionally potent agonists publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.0c02053 – volume: 180 start-page: 655 issue: 4 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib12 article-title: Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures publication-title: Cell doi: 10.1016/j.cell.2020.01.008 – volume: 50 start-page: 4048 issue: 17 year: 2007 ident: 10.1016/j.ejmech.2021.114027_bib14 article-title: C1 ‘-cycloalkyl side chain pharmacophore in tetrahydrocannabinols publication-title: J. Med. Chem. doi: 10.1021/jm070121a – volume: 26 start-page: 4963 issue: 18 year: 2018 ident: 10.1016/j.ejmech.2021.114027_bib28 article-title: Oximes short-acting CB1 receptor agonists publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2018.08.003 – volume: 27 start-page: 221 issue: 3 year: 2013 ident: 10.1016/j.ejmech.2021.114027_bib32 article-title: Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments publication-title: J. Comput. Aided Mol. Des. doi: 10.1007/s10822-013-9644-8 – volume: 48 start-page: 443 issue: 3 year: 1995 ident: 10.1016/j.ejmech.2021.114027_bib26 article-title: Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors publication-title: Mol. Pharmacol. doi: 10.1016/S0026-895X(25)10492-6 – volume: 55 start-page: 10074 issue: 22 year: 2012 ident: 10.1016/j.ejmech.2021.114027_bib21 article-title: Sulfonyl fluoride inhibitors of fatty acid amide hydrolase publication-title: J. Med. Chem. doi: 10.1021/jm301205j – volume: 8 start-page: 17 year: 2016 ident: 10.1016/j.ejmech.2021.114027_bib23 article-title: The structure–function relationships of classical cannabinoids: CB1/CB2 modulation publication-title: Perspect. Med. Chem. – volume: 176 start-page: 448 issue: 3 year: 2019 ident: 10.1016/j.ejmech.2021.114027_bib11 article-title: Structure of a signaling cannabinoid receptor 1-G protein complex publication-title: Cell doi: 10.1016/j.cell.2018.11.040 – volume: vol. 25 start-page: 366 year: 1995 ident: 10.1016/j.ejmech.2021.114027_bib27 article-title: Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors – volume: 53 start-page: 6996 issue: 19 year: 2010 ident: 10.1016/j.ejmech.2021.114027_bib13 article-title: Novel 1',1'-chain substituted hexahydrocannabinols: 9beta-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist publication-title: J. Med. Chem. doi: 10.1021/jm100641g – volume: 59 start-page: 6903 issue: 14 year: 2016 ident: 10.1016/j.ejmech.2021.114027_bib30 article-title: Novel C-Ring-hydroxy-substituted controlled deactivation cannabinergic analogues publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b00717 – volume: 167 start-page: 750 issue: 3 year: 2016 ident: 10.1016/j.ejmech.2021.114027_bib9 article-title: Crystal structure of the human cannabinoid receptor CB1 publication-title: Cell doi: 10.1016/j.cell.2016.10.004 – volume: 23 start-page: 802 issue: 8 year: 2012 ident: 10.1016/j.ejmech.2021.114027_bib17 article-title: Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice publication-title: Behav. Pharmacol. doi: 10.1097/FBP.0b013e32835a7c4d – volume: 16 start-page: 9 issue: 1 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib3 article-title: Cannabinoids and the expanded endocannabinoid system in neurological disorders publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-019-0284-z – volume: 411 start-page: 116717 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib4 article-title: Clinical uses of cannabis and cannabinoids in the United States publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2020.116717 – start-page: 107477 year: 2020 ident: 10.1016/j.ejmech.2021.114027_bib2 article-title: The therapeutic potential of second and third generation CB1R antagonists publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2020.107477 – volume: 220 start-page: 417 issue: 2 year: 2012 ident: 10.1016/j.ejmech.2021.114027_bib18 article-title: AM2389, a high-affinity, in vivo potent CB 1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice publication-title: Psychopharmacology doi: 10.1007/s00213-011-2491-1 – volume: 176 start-page: 448 year: 2019 ident: WOS:000456526100007 article-title: Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex publication-title: CELL doi: 10.1016/j.cell.2018.11.040 – volume: 26 start-page: 795 year: 2017 ident: WOS:000416114000005 article-title: Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study publication-title: AMERICAN JOURNAL ON ADDICTIONS doi: 10.1111/ajad.12622 – volume: 59 start-page: 6903 year: 2016 ident: WOS:000380730600022 article-title: Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.6b00717 – volume: 208 start-page: ARTN 107477 year: 2020 ident: WOS:000522634400012 article-title: The therapeutic potential of second and third generation CB1R antagonists publication-title: PHARMACOLOGY & THERAPEUTICS doi: 10.1016/j.pharmthera.2020.107477 – volume: 318 start-page: 1230 year: 2006 ident: WOS:000239878900035 article-title: Pharmacological characterization of novel water-soluble cannabinoids publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS doi: 10.1124/jpet.106.104109 – volume: 372 start-page: 119 year: 2020 ident: WOS:000507945200012 article-title: Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS doi: 10.1124/jpet.119.261818 – volume: 53 start-page: 6996 year: 2010 ident: WOS:000282544800017 article-title: Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9/β-1-Hydroxy-3-(1-hexyl-cyclobut-l-yl)hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm100641g – volume: 547 start-page: 468 year: 2017 ident: WOS:000406358300039 article-title: Crystal structures of agonist-bound human cannabinoid receptor CB1 publication-title: NATURE doi: 10.1038/nature23272 – volume: 40 start-page: 709 year: 2020 ident: WOS:000485789400001 article-title: Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules publication-title: MEDICINAL RESEARCH REVIEWS doi: 10.1002/med.21634 – volume: 88 start-page: 712 year: 2020 ident: WOS:000564540900001 article-title: Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone publication-title: ANNALS OF NEUROLOGY doi: 10.1002/ana.25864 – volume: 49 start-page: 534 year: 2006 ident: WOS:000234836200015 article-title: Novel procedure for modeling ligand/receptor induced fit effects publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm050540c – volume: 17 start-page: 623 year: 2018 ident: WOS:000443169700010 article-title: New approaches and challenges to targeting the endocannabinoid system publication-title: NATURE REVIEWS DRUG DISCOVERY doi: 10.1038/nrd.2018.115 – volume: 232 start-page: 2751 year: 2015 ident: WOS:000358059700010 article-title: Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist publication-title: PSYCHOPHARMACOLOGY doi: 10.1007/s00213-015-3907-0 – volume: 7 start-page: 863 year: 2012 ident: WOS:000309460800001 article-title: The influence of lipophilicity in drug discovery and design publication-title: EXPERT OPINION ON DRUG DISCOVERY doi: 10.1517/17460441.2012.714363 – start-page: 48 year: 2020 ident: 000819709800001.1 article-title: Natural compounds and synthetic drugs to target type-1 cannabinoid (CB1) receptor publication-title: New Tools to Interrogate Endocannabinoid Signalling – volume: 12 start-page: 281 year: 2016 ident: WOS:000368322500026 article-title: OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins publication-title: JOURNAL OF CHEMICAL THEORY AND COMPUTATION doi: 10.1021/acs.jctc.5b00864 – volume: 55 start-page: 10074 year: 2012 ident: WOS:000311461500055 article-title: Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm301205j – volume: 23 start-page: 802 year: 2012 ident: WOS:000310921700009 article-title: Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice publication-title: BEHAVIOURAL PHARMACOLOGY doi: 10.1097/FBP.0b013e32835a7c4d – volume: 63 start-page: 8112 year: 2007 ident: WOS:000252083800007 article-title: A concise methodology for the synthesis of (-)-Δ9-tetrahydrocannabinol and (-)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs publication-title: TETRAHEDRON doi: 10.1016/j.tet.2007.06.006 – volume: 8 year: 2016 ident: WOS:000383809500001 article-title: The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation publication-title: PERSPECTIVES IN MEDICINAL CHEMISTRY doi: 10.4137/PMC.S32171 – volume: 50 start-page: 4048 year: 2007 ident: WOS:000248758600010 article-title: C1′-cycloalkyl side chain pharmacophore in tetrahydrocannabinols publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm070121a – volume: 16 start-page: 9 year: 2020 ident: WOS:000505736100007 article-title: Cannabinoids and the expanded endocannabinoid system in neurological disorders publication-title: NATURE REVIEWS NEUROLOGY doi: 10.1038/s41582-019-0284-z – volume: 25 start-page: 366 year: 1995 ident: 000819709800001.27 article-title: Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors publication-title: Methods Neurosci – volume: 180 start-page: 655 year: 2020 ident: WOS:000514846600005 article-title: Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures publication-title: CELL doi: 10.1016/j.cell.2020.01.008 – volume: 27 start-page: 1161 year: 2019 ident: WOS:000488523100001 article-title: Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease publication-title: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY doi: 10.1016/j.jagp.2019.05.002 – volume: 26 start-page: 4963 year: 2018 ident: WOS:000446669400001 article-title: Oximes short-acting CB1 receptor agonists publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2018.08.003 – volume: 27 start-page: 221 year: 2013 ident: WOS:000318411400002 article-title: Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments publication-title: JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN doi: 10.1007/s10822-013-9644-8 – volume: 220 start-page: 417 year: 2012 ident: WOS:000300781200016 article-title: AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice publication-title: PSYCHOPHARMACOLOGY doi: 10.1007/s00213-011-2491-1 – volume: 167 start-page: 750 year: 2016 ident: WOS:000386344100021 article-title: Crystal Structure of the Human Cannabinoid Receptor CB1 publication-title: CELL doi: 10.1016/j.cell.2016.10.004 – volume: 58 start-page: 665 year: 2015 ident: WOS:000348492100012 article-title: Probing the Carboxyester Side Chain in Controlled Deactivation (-)-Δ8-Tetrahydrocannabinols publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm501165d – volume: 64 start-page: 3870 year: 2021 ident: WOS:000639043300020 article-title: Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.0c02053 – volume: 48 start-page: 443 year: 1995 ident: WOS:A1995RX63500009 article-title: COMPARISON OF THE PHARMACOLOGY AND SIGNAL-TRANSDUCTION OF THE HUMAN CANNABINOID CB1 AND CB2 RECEPTORS publication-title: MOLECULAR PHARMACOLOGY – volume: 61 start-page: 8639 year: 2018 ident: WOS:000447470700009 article-title: (R)-N-(1-Methyl-2-hydroxyethyl)-13-(S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.8b00611 – volume: 411 start-page: ARTN 116717 year: 2020 ident: WOS:000525420400030 article-title: Clinical uses of cannabis and cannabinoids in the United States publication-title: JOURNAL OF THE NEUROLOGICAL SCIENCES doi: 10.1016/j.jns.2020.116717
SSID	ssj0005600
Score	2.393932
Snippet	In earlier work, we explored the SAR for the C3 side chain pharmacophore in the hexahydrocannabinol template represented by the drug nabilone, which resulted...
Source	Web of Science
SourceID	proquest pubmed webofscience crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	114027
SubjectTerms	Cannabinoids CB1 receptor Chemistry, Medicinal Dronabinol - analogs & derivatives Dronabinol - pharmacology Life Sciences & Biomedicine Nabilone analogs Pharmacology & Pharmacy Receptor, Cannabinoid, CB1 - agonists SAR studies Science & Technology Structure-Activity Relationship
Title	Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists
URI	https://dx.doi.org/10.1016/j.ejmech.2021.114027 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000819709800001 https://www.ncbi.nlm.nih.gov/pubmed/35051750 https://www.proquest.com/docview/2622286552
Volume	230
WOS	000819709800001
WOSCitedRecordID	wos000819709800001
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1768-3254 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005600 issn: 0223-5234 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb5tAEF45SaXmUrXpy31EWynKxcHizXJ03VRND6kPruQbWpalskXBCtiKf0_-aGdYFty6aZJDD0bWAsuKb5idnZn9hpCTFCYVnvrSiF0vNFw7dYw4cVyDSSv2Qy4SbsZ1sYng8pLNZuGk17vRe2HWWZDn7Po6XP5XqKENwMatsw-Au-0UGuA_gA5HgB2O9wJeuQnAjhQbkRXxqtpkgxx5dIscQwXorCmxusyyqDAPYPzRGoDWk8sK0yl_FMikW97qr29s1yYij9wiumBcF4sC_cLB5sTs2loDFVgWqRxMhm2uD_rh5zxR9Aa4W6gojW9YJGTeWvgX2bxYFqsMzkzLYlXBb8236RDK7oFI71u22SuD0XDblQGrYCys4m1pPLBVcGXsbqtnu4nbKAULyzdTkQns6H7lhlgM5eKnrONMtjXsLv-davuPKbBNTNQ5b4tI9RJhL5HqZY8c2IEXguo8GF2cz752mUS-2umkR693aNZphLujuc0C2l3h_NUYqg2f6VPypFmx0JGStGekJ_Mj8niscT8ipxNFf745o9NuN195Rk_ppCNG3zwnn7Ro0k40qRZN2ogm5SVVoklBNKkWTapF8wX5_vl8Ov5iNFU8DOGarDIki10uhJt6TuAlYZAyYaemxSRLLBEzO5WgKxwrsXxPikTIEFpjmBikb8epyRLnJdnPYRivCeVmaEokSIyldE2RcjP1YMJ2w8RxGLdFnzj6zUaiobjHSitZ9C9c-8Ro71oqipc7rg80aFGDjDI_I5DEO-78oDGOACMMzfFcFqsysn30xPqeZ_fJKwV-OxbHQx49z-yTk21paM8rsz4wQ1aH6vrEus9l4-b9IPVF9eaBr-AtOey-33dkv7payffkkViDnrg6JnvBjB03X8kvNWDsXQ
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improved+cyclobutyl+nabilone+analogs+as+potent+CB1+receptor+agonists&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Papanastasiou%2C+Ioannis+P.&rft.au=Georgiadis%2C+Markos-Orestis&rft.au=Iliopoulos-Tsoutsouvas%2C+Christos&rft.au=Paronis%2C+Carol+A.&rft.date=2022-02-15&rft.issn=0223-5234&rft.volume=230&rft.spage=114027&rft_id=info:doi/10.1016%2Fj.ejmech.2021.114027&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ejmech_2021_114027
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon